drugset / Trial / NCT07263165

Dexmedetomidine as an Adjuvant to Bupivacaine for Ultrasound-Guided External Oblique Intercostal Block

NCT07263165 ↗

Not yet recruiting 54 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Effect of Adding Dexmedetomidine as Adjuvant toBupivacaine in Ultrasound Guided ExternalOblique Intercostal Plane Block in UpperAbdominal Cancer Surgery.

Timeline

Start
2025-12-15
Primary completion
2026-02-15
Completion
2027-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Other

Indications

No indication recorded.